Learn everything you need to know about Nabilone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Review the side-effects of Nabilone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

CHICAGO -- Nabilone, a synthetic cannabinoid, improved symptoms of agitation and aggression among Alzheimer's disease patients, researchers reported here. Nabilone (Cesamet) is currently approved for ...

Nabilone — a synthetic cannabinoid — reduced agitation and improved neuropsychiatric symptoms, cognition and nutrition in patients with moderate-to-severe Alzheimer’s disease, according to research ...

Right now, there are 5.7 million Americans living with Alzheimer’s disease. The neurodegenerative condition drastically impacts cognition, affecting memory, coordination, and language. People with ...

Researchers are about to enroll the first patient in a pilot study of potential weight loss with nabilone — a manufactured cannabinoid similar to the active component of the marijuana (cannabis) plant ...

A new study shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week ...

This research will include a randomized controlled trial that will look at if nabilone – a synthetic cannabinoid drug – can reduce body weight in adults with obesity. We are recruiting a sample of 60 ...

Few individuals seeking treatment for marijuana use achieve sustained abstinence. The cannabinoid receptor agonist, Δ 9-tetrahydrocannabinol (THC; dronabinol), decreases marijuana withdrawal symptoms, ...

Co announces it has acquired the commercial rights to nabilone in the United Kingdom and other European mkts from Cambridge Laboratories for $14 mln. Valeant markets nabilone in the United States and ...

SCOTTSDALE, Arizona — Adding a cannabinoid may boost the effectiveness of exposure-based cognitive behavioral therapy (CBT) in patients with obsessive compulsive disorder (OCD), new research suggests.